GlassScriptPhysician profile
Adrian E Park
NPI 1376567099
$355,479.79
in general payments reported to CMS, 2019-2025
8 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87K · 2021: $1,448 · 2022: $142K · 2023: $67K · 2024: $11K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $94K · Travel and Lodging: $29K · Food and Beverage: $1,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $93,870.66 |
| Travel and Lodging | $29,356.44 |
| Food and Beverage | $1,997.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Activ Surgical, INC. | $208,691.65 | 2021-2024 | Activsight |
| Stryker Corporation | $126,021.65 | 2019-2025 | 1588, 1288, 1788 |
| Specialty Surgical Instrumentation | $11,810.79 | 2019 | |
| Cmr Surgical, INC. | $6,529.91 | 2025 | Versius Surgical System (Versius Plus) |
| Distalmotion US | $1,429.97 | 2024 | Dexter L6 Robot |
| Medtronic, INC. | $948.85 | 2024-2025 | Signia, Absorbatack, Ligasure |
| W. L. Gore & Associates, INC. | $27.28 | 2021 | |
| Genentech USA, INC. | $19.69 | 2025 | Ocrevus Zunovo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.